Skip to content

Dr. I. Rogiers

Active
Private limited companyfounded 2006active for 20 yearsElsakkerweg 30, 9830 Sint-Martens-Latem, BelgiumKBO/BCE: BE 0879.350.431
Summary

Dr. I. Rogiers has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €337,404 and a net result of €61,549. Equity is growing by about 33% per year across the filed financial years. Its solvency ranks better than 49% of 244 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€472,260total assets 2026
Equity
€337,404
Profit
€61,549
Turnover not published (micro format)
Financial health
92 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 51 days early
Why 92lowers riskSector: Human health activities (NACE 86)Size: total assets €472,260Figures for financial year 2026 (filed 10-09-2026)Equity €337,404 (71.4% of total assets)Show the evidence

Checked score

Score 2026
92 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 35% of its sector peers (NACE 86, micro)
Financial strength · tick = 2025
Strong
Solvency 96-4
equity 71.4% of total assets
Liquidity 50-21
short-term debt 28.6% · cash 9.4%
Profitability 85-7
return on assets 13.0%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,098 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026highest value
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity ample (current ratio 3.49, compared with 15.04 in 2025, above the usual 1.5; short-term debt: 28.6% and cash: 9.4% of total assets), and 28.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 59% on solvency, 22% on liquidity, 35% on profitability and 23% on growth.

The bankruptcy probability was computed on 21-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €472,260
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2026 (filed 10-09-2026)
NBB · annual accounts
lowers risk · Equity €337,404 (71.4% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 10-09-2026, 51 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
51 days early
2025
91 days early
2024
1 day early
2023
on the day
2022
on the day
2021
2 days early
2020
9 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 19 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 30 October (4 of the last 5 filed years within 50 days of that day).
Companies Code · seven months
Where today falls in the filing period
22-10-2026 today31-03-2027 year end31-10-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2026 · micro…
  2. Annual accounts filedfinancial year 2025 · micro…
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: 8 profitable years in a rowprofit 2026: €61,549 8 years View
  • Positive: Filed on time since financial year 2021accounts within the deadline every year 6 years View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2026
Total assets
€472,260
Profit
€61,549
Solvency
71.4%
Total assets▲ 9.8%
Net result
20192026
Go to Financials

Timeline

Events
27
Since
2008
Next accounts
by 31-10-2027
  1. 18-07-2024Resignation: Isabel Rogiers (director)
  2. 31-03-2024Liquidity more than triples
  3. 31-10-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
02-02-2006
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
18
Who signs
Each director alone
Annual meeting
Third Thursday of August at 20:00
Purpose
“Het uitoefenen,organiseren,bevorderen en structureren van alle activiteiten door de…” (deed in Dutch)
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.